Navigation Links
Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010
Date:2/24/2011

e and price due to competition.  Net sales for the full year were $31.2 million.
  • Tramadol ER:  Net sales for the fourth quarter 2010 were $6.1 compared to $5.5 million in the prior quarter.  Net sales for the full year were $22.6 million. Par Pharmaceutical remains one of only two suppliers of tramadol ER since its launch in November 2009.

  • Other generic products:  For the fourth quarter 2010, net sales from all other generic products were $68.2 million. When adjusted for certain events, fourth quarter net sales were $57.2 million. This compares to adjusted third quarter net sales of $62.2 million.  

  • Megace® ES:  Net sales were $14.8 million for the fourth quarter compared to $16.8 million in the third quarter.  The decrease was due to a decrease in volume and an increase in returns.  Net sales for the full year were $60.9 million.

  • Nascobal® B12 Nasal Spray:  Net sales were $4.8 million for the three months ended December 31, 2010 compared to $4.9 million in the third quarter.  Net sales for the full year were $17.7 million.

  • Total net revenues for the three months ended December 31, 2010, were $227.0 million compared to $290.3 million from prior year, principally driven by additional competition in metoprolol, meclizine, and clonidine.

    Gross margin for the fourth quarter 2010 increased compared to the prior year due primarily to the launches of omeprazole, diazepam, and hydrocodone polistirex and chlorpheniramine polistirex, as well as increases in other generic products.  These gains were partially offset by lower metroprolol, clonidine and meclizine sales and the impact of U.S. healthcare reform enacted in 2010.4Q 20104Q 2009$%$%Key Par (Generic) Products (1)$   42.7

    31.6%$   45.2

    21.6%All other Par (Generic)36.2

    53.1%27.0

    48.6%Total Par (Generic)$   78.9

    38.8%$
    '/>"/>

    SOURCE Par Pharmaceutical Companies, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
    2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
    9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2015)... and KING OF PRUSSIA, Pa. , May ... has awarded CSL Behring its 2015 Corporate Leadership ... to advancing science and improving the care of the bleeding ... , CEO and Managing Director, CSL Limited, during the NHF ... on May 21. "The National Hemophilia Foundation ...
    (Date:5/22/2015)... According to a new market research report ... by Test Type (Indirect, Enzyme-based, Reactive Oxygen Species (ROS)-based), ... - Global Forecast to 2020", published by MarketsandMarkets, the global ... Million by 2020 from $452.36 Million in 2015, growing ... 71 market data Tables and 90 Figures spread through ...
    (Date:5/22/2015)... DUBLIN , May 22, 2015 Research ... announced the addition of the "Latest Regulations ... report to their offering. This ... officially issued a guidance on international multi-center clinical ... , which has begun to be implemented on ...
    Breaking Medicine Technology:National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 42015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
    ... Technologies Inc. (OTCBB: MDCE), a children,s healthcare service provider, ... common stock held on February 29, 2012 at 10:00 a.m. ... Meeting will occur on March 29, 2012 at 10:00 a.m. ... ensure that their voting instructions are carried out on proposed ...
    ... SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ... 7)*REPLIGEN CORP (Name of Issuer)Common Stock, Par Value $0.01 Per ... Barry L. Fischer Thompson Coburn LLP 55 East ... Address and Telephone Number of Person Authorized to Receive Notices ...
    Cached Medicine Technology:Medical Care Technologies Inc. Announces Adjournment of Special Meeting 2Medical Care Technologies Inc. Announces Adjournment of Special Meeting 3Major Repligen (Nasdaq: RGEN) Shareholder Files Amended 13D 2Major Repligen (Nasdaq: RGEN) Shareholder Files Amended 13D 3Major Repligen (Nasdaq: RGEN) Shareholder Files Amended 13D 4Major Repligen (Nasdaq: RGEN) Shareholder Files Amended 13D 5
    (Date:5/24/2015)... EnviroLeatherâ„¢ by LDI, a leader ... a classic, rugged leather grain with enhanced stain ... including ink, to be easily removed. The collection ... corporate, healthcare, hospitality and education environments. , InkGard ... of developing products that are more sustainable, less ...
    (Date:5/24/2015)... ProPin is a set of self-animating 3D pin markers ... to pin point locations on a map, to indicate prices or ... users to choose from 30 simplistic presets with geometric design elements ... editors can easily manipulate ProPin presets as a whole. Pixel ... , Using ProPin is easy, simply drag a preset into the ...
    (Date:5/24/2015)... Arizona (PRWEB) May 24, 2015 ... former Millennial Media strategy executive Jay Krihak as ... Medicx looks to ramp up its expertise and ... of the Pharmaceutical and Health sectors. , Krihak ... tech executive. Most recently, Krihak led sales planning ...
    (Date:5/24/2015)... May 24, 2015 A report ... that the single best option for avoiding cardiovascular disease ... fitness level was the single most powerful predictor of ... such as diabetes and family history of premature death ... lifelong heart and lung fitness. , The Importance of ...
    (Date:5/23/2015)... 2015 On May 13, Nithyananda Yoga ... youngster's yogic power learned through meditation and initiation at ... Bangalore, India. , Yogamaatha, a nine-year-old girl from North ... profile professionals attending the 2015 Business Advocacy Summit at ... blindfolded. , In a demonstration that lasted three ...
    Breaking Medicine News(10 mins):Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Medicx Media Solutions Expands Executive Team 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3
    ... Announces a 16 Pound Weight Loss in First Seven ... Craig, Inc, one of the nation,s leading authorities on ... Angeles to announce Phylicia Rashad as the newest Jenny ... the importance of life balance and is looking forward ...
    ... Strategic Air and Space Museum show Brain - toys available ... Fat Brain Toy Co. announced today that they ... ,Brain: The World Inside Your Head, on opening day January ... and the museum is located at 28210 West Park Highway ...
    ... In the year following Hurricane Katrina, the health of ... of a national sample of older adults not affected ... researchers at the Johns Hopkins Bloomberg School of Public ... most powerful and deadliest hurricanes in U.S. history. Hurricane ...
    ... A study from the University of Bath has found that ... they use a support group rather than trying to give ... Control Studies led by Dr Linda Bauld at Bath, along ... in the February issue of Addiction journal comparing ...
    ... Denver Broncos star to serve as U.S. ambassador for ... quarterback Jay Cutler is reaching out to help send ... diagnosed with type 1 diabetes last spring and established ... top young quarterbacks with a Pro Bowl season in ...
    ... Jan. 22 When anthrax was sent through the ... postal workers elected not to be inoculated with the ... a University of Pittsburgh Graduate School of Public Health ... the attacks this year, lingering suspicion and uncertainty remain, ...
    Cached Medicine News:Health News:Phylicia Rashad Selected as New Spokesperson for Jenny Craig 2Health News:Decline in health among older adults affected by Hurricane Katrina 2Health News:I quit, we quit -- what works better for smokers? 2Health News:NFL Quarterback Jay Cutler to Help Families Affected by Diabetes by Joining Lilly's Inspired by Diabetes Campaign 2Health News:NFL Quarterback Jay Cutler to Help Families Affected by Diabetes by Joining Lilly's Inspired by Diabetes Campaign 3Health News:NFL Quarterback Jay Cutler to Help Families Affected by Diabetes by Joining Lilly's Inspired by Diabetes Campaign 4Health News:NFL Quarterback Jay Cutler to Help Families Affected by Diabetes by Joining Lilly's Inspired by Diabetes Campaign 5Health News:Revisiting the anthrax attacks 2
    ... The programmer for the ITREL 3 ... programmer and the Model 7457 MemoryMod ... indicated for the treatment of chronic nausea ... drug therapies are not providing adequate relief ...
    ... Rapid diagnosis of influenza A ... important due to the availability ... diagnosis of influenza using Clearview ... can lead to reduced hospital ...
    ... ability of the visual system to ... are,some pathological conditions that reduce contrast ... test will help in the identification ... and reduced visual acuity often occur ...
    ...
    Medicine Products: